Published in J Reticuloendothel Soc on March 01, 1982
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol (1983) 1.65
Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells. J Exp Med (1982) 1.58
The development of cytochrome b-245 in maturing human macrophages. Biochem J (1986) 0.90
Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages. Biochem J (1986) 0.85
Decreased superoxide production, degranulation, tumor necrosis factor alpha secretion, and CD11b/CD18 receptor expression by adherent monocytes from preterm infants. Clin Diagn Lab Immunol (1999) 0.83
Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85
The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest (1975) 7.40
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med (1978) 6.50
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol (1985) 5.02
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34
Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J Exp Med (1976) 3.19
Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med (1980) 3.13
An abnormality of the alternate pathway of complement activation in sickle-cell disease. N Engl J Med (1973) 3.11
Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med (1980) 2.96
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest (1976) 2.85
Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81
Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest (1981) 2.66
Preclinical evaluation of a rheolytic catheter for percutaneous coronary artery/saphenous vein graft thrombectomy. J Invasive Cardiol (1999) 2.66
A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase. Science (1984) 2.53
Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. J Immunol (1980) 2.47
Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J Immunol (1979) 2.47
The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology (1980) 2.35
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest (1986) 2.22
Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol (1982) 2.19
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med (1970) 2.08
Oxygen metabolism and the microbicidal activity of macrophages. Fed Proc (1978) 2.04
Monocyte function in children with neutropenia and chronic infections. Blood (1972) 1.98
Improvement of leukocyte bactericidal activity in chronic granulomatous disease. Blood (1970) 1.90
Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J Exp Med (1984) 1.85
Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages. J Reticuloendothel Soc (1980) 1.85
Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide. J Exp Med (1980) 1.79
Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics (1971) 1.76
Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. J Clin Invest (1985) 1.67
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol (1983) 1.65
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol (1991) 1.58
The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem (1984) 1.57
Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J Clin Invest (1983) 1.54
Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol (1978) 1.54
Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest (1989) 1.53
Phorbol myristate acetate mediates redistribution of protein kinase C in human neutrophils: potential role in the activation of the respiratory burst enzyme. J Immunol (1985) 1.52
Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50
S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem (1994) 1.46
Oxidative metabolism of the human eosinophil. Blood (1977) 1.45
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 1.42
Secondary disorders of the complement system. Am J Dis Child (1989) 1.42
Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes. J Clin Invest (1976) 1.41
Metabolic and bactericidal activities of human eosinophils. Br J Haematol (1971) 1.41
Chronic granulomatous disease. Pediatr Clin North Am (1977) 1.39
An overview of infant mortality and birth defects in the United States. Teratology (1997) 1.38
Tubewell water quality and predictors of contamination in three flood-prone areas in Bangladesh. J Appl Microbiol (2008) 1.37
The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage. Rev Infect Dis (1981) 1.35
The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol (1988) 1.33
Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme. J Immunol (1983) 1.33
Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen. Proc Natl Acad Sci U S A (1972) 1.32
Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect Immun (1974) 1.30
Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am (1988) 1.28
Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med (1970) 1.27
Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun (1973) 1.27
Complement and host defense against infection. J Pediatr (1977) 1.26
Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events. J Clin Invest (1979) 1.26
Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol (1978) 1.26
S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. Arch Biochem Biophys (1994) 1.26
Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun (1985) 1.26
Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc (1972) 1.25
Molecular basis for the enhanced respiratory burst of activated macrophages. Fed Proc (1985) 1.23
Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis (1981) 1.21
Humoral and formed elements of blood modulate the response of peripheral blood monocytes. I. Plasma and serum inhibit and platelets enhance monocyte adherence. J Immunol (1979) 1.20
Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med (1978) 1.20
NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am J Respir Crit Care Med (1999) 1.18
Effect of cyanide on NADPH oxidation by granules from human polymorphonuclear leukocytes. Blood (1977) 1.17
Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C. J Biol Chem (1987) 1.17
Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J Pediatr (1979) 1.16
D2O-alanine exchange reactions catalyzed by alanine racemase and glutamic pyruvic transminase. Biochem Biophys Res Commun (1974) 1.16
Phorbol myristate acetate induces neutrophil NADPH-oxidase activity by two separate signal transduction pathways: dependent or independent of phosphatidylinositol 3-kinase. J Leukoc Biol (2000) 1.16
Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease. J Clin Invest (1988) 1.16
Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J Exp Med (1981) 1.16
Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem (1983) 1.15
Chronic familial granulomatosis. Report of five cases and review of the literature. Am J Dis Child (1967) 1.13
Reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate diaphorase activity in human polymorphonuclear leukocytes. Infect Immun (1974) 1.12
Immunoglobulins of the middle ear fluid in acute otitis media: relationship to serum immunoglobulin concentrations and bacterial cultures. Infect Immun (1973) 1.12
Chemoattractant-elicited alterations of cAMP levels in human polymorphonuclear leukocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase. J Biol Chem (1985) 1.12
The role of an activatable esterase in immune-dependent phagocytosis by human neutrophils. J Immunol (1977) 1.10
Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J Immunol (1978) 1.10
Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest (1991) 1.10
The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza. J Infect Dis (1975) 1.09
Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol (1994) 1.09
Phosphatidic acid-mediated phosphorylation of the NADPH oxidase component p47-phox. Evidence that phosphatidic acid may activate a novel protein kinase. J Biol Chem (1997) 1.08